Page 1912 - Williams Hematology ( PDFDrive )

1886 Part XII: Hemostasis and Thrombosis Chapter 112: Platelet Morphology, Biochemistry, and Function 1887

58. Prevost N, et al: Eph kinases and ephrins support thrombus growth and stability 92. Baglia FA, et al: The glycoprotein Ib-IX-V complex mediates localization of factor XI
by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci U S A to lipid rafts on the platelet membrane. J Biol Chem 278(24):21744–21750, 2003.
102(28):9820–9825, 2005. 93. Brownlow SL, et al: A role for hTRPC1 and lipid raft domains in store-mediated cal-
59. Renne T, et al: Defective thrombus formation in mice lacking coagulation factor XII. cium entry in human platelets. Cell Calcium 35(2):107–113, 2004.
J Exp Med 202(2):271–281, 2005. 94. Lopez JA, I. del Conde, Shrimpton CN: Receptors, rafts, and microvesicles in throm-
60. Jirouskova M, et al: Antibody blockade or mutation of the fibrinogen gamma-chain bosis and inflammation. J Thromb Haemost 3(8):1737–1744, 2005.
C-terminus is more effective in inhibiting murine arterial thrombus formation than 95. White JG: Anatomy and structural organization of the platelet, in Hemostasis and
complete absence of fibrinogen. Blood 103(6):1995–2002, 2004. Thrombosis: Basic Principles and Clinical Practice, edited by RW Colman, VJ Marder,
61. Loscalzo J, Inbal A, Handin RI: Von Willebrand protein facilitates platelet incorpora- EW Salzman, pp 397–413. JB Lippincott, Philadelphia, 1993.
tion in polymerizing fibrin. J Clin Invest 78(4):1112–1119, 1986. 96. Behnke O: The morphology of blood platelet membrane systems. Ser Haematol
62. Deckmyn H, et al: Inhibitors of the interactions between collagen and its receptors on 3(4):3–16, 1970.
platelets. Handb Exp Pharmacol 2012(210):311–337. 97. White JG: Electron microscopic studies of platelet secretion. Prog Hemost Thromb
63. George JN, et al: Platelet surface glycoproteins. Studies on resting and activated platelets and 2:49, 1974.
platelet membrane microparticles in normal subjects, and observations in patients during 98. Suzuki H, Yamazaki H, Tanoue K: Immunocytochemical studies on co-localization
adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78(2):340–348, 1986. of alpha-granule membrane alphaIIbbeta3 integrin and intragranular fibrinogen
64. Michelson AD: Thrombin-induced down-regulation of the platelet membrane glyco- of human platelets and their cell-surface expression during the thrombin-induced
protein Ib-IX complex. Semin Thromb Hemost 18(1):18–27, 1992. release reaction. J Electron Microsc (Tokyo) 52(2):183–195, 1970.
65. Michelson AD, Barnard MR: Thrombin-induced changes in platelet membrane glyco- 99. Stenberg PE, Shuman MA, Levine SP, Bainton DF: Redistribution of α granules and
proteins Ib, IX, and IIb-IIIa complex. Blood 70(5):1673–1678, 1987. their contents in thrombin-stimulated platelets. J Cell Biol 98:748–760, 1984.
66. McEver RP: Properties of GMP-140, an inducible granule membrane protein of plate- 100. Ginsberg MH, Taylor L, Painter RG: The mechanism of thrombin-induced platelet
lets and endothelium. Blood Cells 16(1):73–80; discussion 80–83, 1990. factor 4 secretion. Blood 55:661, 1980.
67. McEver RP, et al: GMP-140, a platelet alpha-granule membrane protein, is also syn- 101. Nurden P, Heilmann E, Paponneau A, Nurden A: Two-way trafficking of membrane
thesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin glycoproteins on thrombin-activated human platelets. Semin Hematol 1994;31(3):
Invest 84(1):92–99, 1989. 240–250, 1980.
68. McEver R: P-selectin/PSGL-1 and other interactions between platelets, leukocytes, and 102. Michelson AD, Barnard MR: Plasmin-induced redistribution of platelet glycoprotein
endothelium, in Platelets, edited by AD M, p 231. Academic Press, San Diego, 2007. Ib. Blood 76(10):2005–2010, 1990.
69. Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ 103. Suzuki H, Nakamura S, Itoh Y, et al: Immunocytochemical evidence for the transloca-
Res 88(8):756–762, 2001. tion of α-granule membrane glycoprotein IIb/IIIa (integrin αIIbβ3) of human platelets
70. Luscher TF: Platelet-vessel wall interaction: Role of nitric oxide, prostaglandins and to the surface membrane during the release reaction. Histochemistry 97:381–388, 1992.
endothelins. Baillieres Clin Haematol 6(3):609–627, 1993. 104. Suzuki H, Murasaki K, Kodama K, Takayama H: et al: Intracellular localization of
71. Mitchell JA, et al: Role of nitric oxide and prostacyclin as vasoactive hormones glycoprotein VI in human platelets and its surface expression upon activation. Br J
released by the endothelium. Exp Physiol 93(1):141–147, 2008. Haematol 121(6):904–912, 2003.
72. Rex S, Freedman JE: Inhibition of platelet function by the endothelium, in Platelets, 105. Nurden P, Poujol C, Winckler J, et al: Immunolocalization of P2Y1 and TPalpha
edited by AD Michelson, pp 251–280. Academic Press, San Diego, 2007. receptors in platelets showed a major pool associated with the membranes of alpha-
73. Marcus AJ, et al: The endothelial cell ecto-ADPase responsible for inhibition of plate- granules and the open canalicular system. Blood 101(4):1400–1408, 2003.
let function is CD39. J Clin Invest 99(6):1351–1360, 1997. 106. Breton-Gorius, J, Guichard J: Ultrastructural localization of peroxidase activity in
74. Marcus AJ, et al: Inhibition of platelet function by an aspirin-insensitive endothelial cell human platelets and megakaryocytes. Am J Pathol 66:277, 1986.
ADPase. Thromboregulation by endothelial cells. J Clin Invest 88(5):1690–1696, 1991. 107. Cramer EM: Platelets and megakaryocytes: Anatomy and structural organization,
75. Holme S, et al: Light scatter and total protein signal distribution of platelets by flow in Hemostasis and Thrombosis: Basic Principles in Clinical Practice, edited by RW
cytometry as parameters of size. J Lab Clin Med 112(2):223–231, 1988. Colman, J Hirsh, V J Marder, AW Clowes and J N George, et al, pp 411–428. Lippincott,
76. White J: Anatomy and structural organization of the platelet, in Hemostasis and Williams & Wilkins: Philadelphia, 2001.
Thrombosis: Basic Principles and Clinical Practice, edited by RW Colman, VJ Marder, 108. White JG: Interaction of membrane systems in blood platelets. Am J Pathol 66(2):
EW Salzman, p 397. JB Lippincott, Philadelphia, 1993. 295–312, 1972.
77. Coller BS: Biochemical and electrostatic considerations in primary platelet aggrega- 109. Menashi S, Davis C, Crawford N: Calcium uptake associated with an intracellular
tion. Ann N Y Acad Sci 416:693–708, 1983. membrane fraction prepared from human blood platelets by high-voltage, free-flow
78. van Joost T, et al: Purpuric contact dermatitis to benzoyl peroxide. J Am Acad Derma- electrophoresis. FEBS Lett 140:298, 1982.
tol 22(2 Pt 2):359–361, 1990. 110. Robblee LS, Shepro D, Belamarich FA: Calcium uptake and associated adenosine tri-
79. Schick P: Megakaryocyte and platelet lipids, in Hemostasis and Thrombosis: Basic phosphate activity of isolated platelet membranes. J Gen Physiol 61:462, 1973.
Principles and Clinical Practice, edited by RW Colman, VJ Marder, EW Salzman, 111. Hartwig JH: Platelet morphology, in Thrombosis and Hemorrhage, edited by J
p 574. JB Lippincott, Philadelphia, 1993. Loscalzo, AI Schafer, pp 207–228. Williams & Wilkins, Baltimore, 1999.
80. Heemskerk JW, Bevers EM, Lindhout T: Platelet activation and blood coagulation. 112. Michalak M, Mariani P, Opas M: Calreticulin, a multifunctional Ca2+ binding chap-
Thromb Haemost 88(2):186–193, 2002. erone of the endoplasmic reticulum. Biochem Cell Biol 76(5):779–785, 1998.
81. Solum NO: Procoagulant expression in platelets and defects leading to clinical disor- 113. Brownlow SL, Sage SO: Rapid agonist-evoked coupling of type II Ins(1,4,5)P3 recep-
ders. Arterioscler Thromb Vasc Biol 19(12):2841–2846, 1999. tor with human transient receptor potential (hTRPC1) channels in human platelets.
82. Sims PJ, et al: Complement proteins C5b-9 cause release of membrane vesicles from Biochem J 375(Pt 3):697–704, 2003.
the platelet surface that are enriched in the membrane receptor for coagulation factor 114. van Gorp RM, et al: Irregular spiking in free calcium concentration in single, human
Va and express prothrombinase activity. J Biol Chem 263(34):18205–18212, 1988. platelets. Regulation by modulation of the inositol trisphosphate receptors. Eur J Bio-
83. Sims PJ, et al: Assembly of the platelet prothrombinase complex is linked to vesicula- chem 269(5):1543–1552, 2002.
tion of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect 115. Käser-Glanzmann R, Jakábová M, George JN, Lüscher EF: Further characterization
in platelet procoagulant activity. J Biol Chem 264(29):17049–17057, 1989. of calcium accumulating vesicles from human blood platelets. Biochim Biophys Acta
84. Bevers EM, et al: Exposure of endogenous phosphatidylserine at the outer surface 542:357, 1978.
of stimulated platelets is reversed by restoration of aminophospholipid translocase 116. Tertyshnikova S, Fein A: Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+
activity. Biochemistry 28(6):2382–2387, 1989. release by cAMP- dependent protein kinase in a living cell. Proc Natl Acad Sci U S A
85. Comfurius P, Bevers EM, Zwaal RF: The involvement of cytoskeleton in the regulation 1998;95(4):1613–1617, 1978.
of transbilayer movement of phospholipids in human blood platelets. Biochim Biophys 117. Pernollet MG, Lantoine F, Devynck MA: Nitric oxide inhibits ATP-dependent Ca
2+
Acta 815(1):143–148, 1985. uptake into platelet membrane vesicles. Biochem Biophys Res Commun 222(3):
86. Tuszynski GP, et al: The platelet cytoskeleton contains elements of the prothrombinase 780–785, 1996.
complex. J Biol Chem 259(11):6947–6951, 1984. 118. Teijeiro RG, et al: Calcium efflux from platelet vesicles of the dense tubular sys-
87. Bodin S, Tronchere H, Payrastre B: Lipid rafts are critical membrane domains in blood tem. Analysis of the possible contribution of the Ca pump. Mol Cell Biochem
2+
platelet activation processes. Biochim Biophys Acta 1610(2):247–257, 2003. 199(1–2):7–14, 1999.
88. Locke D, et al: Lipid rafts orchestrate signaling by the platelet receptor glycoprotein 119. Bergmeier W, Stefanini L: Novel molecules in calcium signaling in platelets. J Thromb
VI. J Biol Chem 277(21):18801–18809, 2002. Haemost 7(Suppl 1):187–190, 2009.
89. Shrimpton CN, et al: Localization of the adhesion receptor glycoprotein Ib-IX-V 120. Dziadek MA, Johnstone LS: Biochemical properties and cellular localisation of STIM
complex to lipid rafts is required for platelet adhesion and activation. J Exp Med proteins. Cell Calcium 42(2):123–132, 2007.
196(8):1057–1066, 2002. 121. Grosse J, et al: An EF hand mutation in Stim1 causes premature platelet activation and
90. Heijnen HF, et al: Concentration of rafts in platelet filopodia correlates with recruit- bleeding in mice. J Clin Invest 117(11):3540–3550, 2007.
ment of c-Src and CD63 to these domains. J Thromb Haemost 1(6):1161–1173, 2003. 122. Varga-Szabo D, et al: The calcium sensor STIM1 is an essential mediator of arterial
91. Bodin S, et al: Production of phosphatidylinositol 3,4,5-trisphosphate and phosphat- thrombosis and ischemic brain infarction. J Exp Med 205(7):1583–1591, 2008.
idic acid in platelet rafts: Evidence for a critical role of cholesterol-enriched domains 123. Bergmeier W, et al: R93W mutation in Orai1 causes impaired calcium influx in plate-
in human platelet activation. Biochemistry 40(50):15290–15299, 2001. lets. Blood 113(3):675–678, 2009.

Kaushansky_chapter 112_p1829-1914.indd 1887 17/09/15 3:30 pm